EGFR and non-small cell lung carcinoma: Since EGFR internalization/translocation is known to be perturbed by the presence of TKIs (60), we therefore investigated the roles of identified PPIs in EGFR trafficking mechanisms upon gefitinib treatment in NSCLC cells.